"Cushing Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Descriptor ID |
D003480
|
| MeSH Number(s) |
C19.053.800.367
|
| Concept/Terms |
Cushing Syndrome- Cushing Syndrome
- Syndrome, Cushing
- Cushing's Syndrome
- Syndrome, Cushing's
- Hypercortisolism
|
Below are MeSH descriptors whose meaning is more general than "Cushing Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Cushing Syndrome".
This graph shows the total number of publications written about "Cushing Syndrome" by people in this website by year, and whether "Cushing Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cushing Syndrome" by people in Profiles.
-
Delivanis DA, I?iguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, Thomas MA, Gogos C, Young WF, Bancos I, Kyriazopoulou V. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018 02; 88(2):209-216.
-
Carney JA, Stratakis CA, Young WF. Adrenal cortical adenoma: the fourth component of the Carney triad and an association with subclinical Cushing syndrome. Am J Surg Pathol. 2013 Aug; 37(8):1140-9.
-
Albert NE, Kazi S, Santoro J, Dougherty R. Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome. Am J Med Sci. 2012 Jul; 344(1):72-4.
-
Markou A, Manning P, Kaya B, Datta SN, Bomanji JB, Conway GS. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome. Eur J Endocrinol. 2005 Apr; 152(4):521-5.
-
George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF, Lloyd RV, Meyer FB. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol. 2003 Oct; 27(10):1330-6.
-
Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003; 4(5):315-31.
-
Veznedaroglu E, Armonda RA, Andrews DW. Diagnosis and therapy for pituitary tumors. Curr Opin Oncol. 1999 Jan; 11(1):27-31.
-
Leibowitz J, Pertsemlidis D, Gabrilove JL. Recurrent Cushing's syndrome due to recurrent adrenocortical tumor--fragmentation or tumor in ectopic adrenal tissue? J Clin Endocrinol Metab. 1998 Nov; 83(11):3786-9.
-
Andrews DW. Pituitary adenomas. Curr Opin Oncol. 1997 Jan; 9(1):55-60.
-
Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab. 1995 Feb; 80(2):412-7.